BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jun 30, 2008
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 6/27 cls
Alkermes (NASDAQ:ALKS) Banc of America Securities William Ho Price target Buy -1% $12.70
Ho raised his target to $16.50 from $14 after Alkermes announced new financial guidance and an increase in the value of the share repurchase program to $215M from $175M. He believes the repurchase will provide additional support to the stock. To date the company has repurchased 8M shares for about $106M. Ho also raised his FY09 revenue estimates to $212.7M from $187.2M and his FY09 EPS estimates to $0.11 from a loss of $0.15.
Ambrilia (TSX:AMB) Dundee...

Read the full 682 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >